These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 19365054)

  • 21. Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.
    Penny S; Khaleeli Z; Cipolotti L; Thompson A; Ron M
    Neurology; 2010 Feb; 74(7):545-52. PubMed ID: 20157157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
    Zivadinov R; Locatelli L; Cookfair D; Srinivasaraghavan B; Bertolotto A; Ukmar M; Bratina A; Maggiore C; Bosco A; Grop A; Catalan M; Zorzon M
    Mult Scler; 2007 May; 13(4):490-501. PubMed ID: 17463072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G; Lavorgna L; Russo P; Prinster A; Dinacci D; Savettieri G; Quattrone A; Livrea P; Messina C; Reggio A; Bresciamorra V; Orefice G; Paciello M; Brunetti A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Patti F; Salemi G; Cammarata E; Simone IL; Salvatore M; Bonavita V; Alfano B
    Neurology; 2005 Jul; 65(2):280-5. PubMed ID: 16043800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis.
    Calabrese M; Battaglini M; Giorgio A; Atzori M; Bernardi V; Mattisi I; Gallo P; De Stefano N
    Neurology; 2010 Oct; 75(14):1234-40. PubMed ID: 20739644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical lesion load associates with progression of disability in multiple sclerosis.
    Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P
    Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical lesions in radiologically isolated syndrome.
    Giorgio A; Stromillo ML; Rossi F; Battaglini M; Hakiki B; Portaccio E; Federico A; Amato MP; De Stefano N
    Neurology; 2011 Nov; 77(21):1896-9. PubMed ID: 22076541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
    Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
    Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.
    Charil A; Dagher A; Lerch JP; Zijdenbos AP; Worsley KJ; Evans AC
    Neuroimage; 2007 Jan; 34(2):509-17. PubMed ID: 17112743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging.
    Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergström J; Flodmark O; Aspelin P; Wiberg MK
    Acta Radiol; 2009 Oct; 50(8):924-32. PubMed ID: 19639474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lesion enhancement diminishes with time in primary progressive multiple sclerosis.
    Khaleeli Z; Ciccarelli O; Mizskiel K; Altmann D; Miller DH; Thompson AJ
    Mult Scler; 2010 Mar; 16(3):317-24. PubMed ID: 20203148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance evidence of cortical onset of multiple sclerosis.
    Calabrese M; Gallo P
    Mult Scler; 2009 Aug; 15(8):933-41. PubMed ID: 19667021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.
    Agosta F; Rovaris M; Pagani E; Sormani MP; Comi G; Filippi M
    Brain; 2006 Oct; 129(Pt 10):2620-7. PubMed ID: 16951409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis.
    Mesaros S; Rovaris M; Pagani E; Pulizzi A; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2008 Sep; 65(9):1223-30. PubMed ID: 18779427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.